Elucidating the genotype-phenotype relationships and network perturbations of human shared and specific disease genes from an evolutionary perspective

Abstract

To date, numerous studies have been attempted to determine the extent of variation in evolutionary rates between human disease and nondisease (ND) genes. In our present study, we have considered human autosomal monogenic (Mendelian) disease genes, whichwere classified into two groups according to the number of phenotypic defects, that is, specific disease (SPD) gene (one gene: One defect) and shared disease (SHD) gene (one gene :multiple defects). Here,we have compared the evolutionary rates of these two groups of genes, that is, SPD genes and SHD genes with respect to ND genes. We observed that the average evolutionary rates are slowinSHDgroup, intermediate inSPD group, and fast inND group. Group-to-group evolutionary rate differences remain statistically significant regardless of their gene expression levels and number of defects. We demonstrated that disease genes are under strong selective constraint if they emerge through edgetic perturbation or drug-induced perturbation of the interactome network, show tissue-restricted expression,and are involved in transmembrane transport. Amongall the factors, our regression analyses interestingly suggest the independent effects of 1) drug-induced perturbation and 2) the interaction term of expression breadth and transmembrane transport on protein evolutionary rates. We reasoned that the drug-induced network disruption is a combination of several edgetic perturbations and, thus, has more severe effect on gene phenotypes.